Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study.
about
A CRISPR toolbox to study virus-host interactionsA CRISPR/Cas9 guidance RNA screen platform for HIV provirus disruption and HIV/AIDS gene therapy in astrocytes.CRISPR Editing Technology in Biological and Biomedical Investigation.CRISPR-Cas orthologues and variants: optimizing the repertoire, specificity and delivery of genome engineering tools.Development of europium doped core-shell silica cobalt ferrite functionalized nanoparticles for magnetic resonance imaging.In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition.Disruption or Excision of Provirus as an Approach to HIV Cure.Clinical Applications of Genome Editing to HIV Cure.Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants.Cell and Gene Therapy for HIV Cure.Genome editing technologies to fight infectious diseases.What do we measure when we measure cell-associated HIV RNA.CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy.In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.Synthetic AAV/CRISPR vectors for blocking HIV-1 expression in persistently infected astrocytes.In vivo genome editing thrives with diversified CRISPR technologies.Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice.The Role of Gene Editing in Neurodegenerative Diseases.CRISPR-mediated genome editing and human diseasesIn Vivo Genome Editing as a Therapeutic ApproachInhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9Comprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profilingDisruption by SaCas9 Endonuclease of HERV-K, a Retroviral Gene with Oncogenic and Neuropathogenic Potential, Inhibits Molecules Involved in Cancer and Amyotrophic Lateral SclerosisClass 2 CRISPR/Cas: an expanding biotechnology toolbox for and beyond genome editing
P2860
Q29994612-2907983F-27D4-43B9-BB5E-8CE3E7805F5EQ38654059-B6DA631F-B4E0-4629-9C98-4428B9C92316Q38688945-59E7468D-248E-408D-A710-D79CF944C230Q38716317-AA8201C1-A874-4C52-85DC-01B07615BC30Q38787356-A19D4C24-7324-47B3-A3BE-5736BF286CE8Q40263108-0F1C58CB-BCD7-45D7-B810-8CEEC957A5BDQ40279377-6F4B5B2B-65F1-45D0-965E-EF207C59B662Q40448071-D0E68F41-F8F6-48BA-B1B4-ECD142AC93EEQ40448468-07E05133-5953-4D22-8DEB-F995CB0DE212Q43212335-9C8B2841-4194-4F72-89F5-A381075DE5F7Q47236016-FD8C08FA-673D-4BA2-B3BC-48D9B06F63ABQ47392998-A318B69A-59E2-41B8-9181-83DE507C7F6BQ47548192-64F068C3-D891-4537-84B6-5307B94A54B4Q47549689-53F998DF-7350-40D8-8D0D-F8C1C7E606FDQ47553089-413CB9E6-55A1-45D5-B649-B7EBF965EB67Q47553772-66C7CEB9-16E1-4A91-A75F-C4256496318CQ47585560-53039631-1FC0-4885-B71E-9EF05EBBDC7BQ52363995-D557A9F7-FFBC-41AC-9B73-22D285E2A7AFQ55346907-F6CD263E-89AE-4FE2-8C07-7E989A45260AQ55709239-46EEAED5-7464-4EEF-9D5A-670666F405C0Q57253681-E0E72C9F-DE6B-4784-BF88-E9C6BE147A89Q58745391-978B49E8-4D92-4205-9A93-C9DDDB0CD67FQ58750557-260A28B5-F80D-4140-873F-16FB8D58270EQ58755636-1829B374-14CC-47EE-BBE9-FE144EFCE336Q58796885-2EECC715-962D-4498-BFFA-115A9CE7041BQ59127565-F87D3054-1D88-4068-9834-7C4B1B9CDAB2
P2860
Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study.
@en
type
label
Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study.
@en
prefLabel
Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study.
@en
P2093
P2860
P50
P356
P1433
P1476
Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study.
@en
P2093
H E Gendelman
P Ferrante
P2860
P2888
P304
P356
10.1038/GT.2016.41
P577
2016-05-19T00:00:00Z
P6179
1005966760